TARGIMMUNE THERAPEUTICS
TargImmune Therapeutics AG is a private Swiss-based biotechnology company focused on drug development using novel targeted onco-immunotherapies. The Company’s principal technology is the CTPIC technology platform that utilizes a non-viral vector to target and destroy cancer cells that over-express certain receptors while simultaneously eliciting an immune response against the cancer cells.
TARGIMMUNE THERAPEUTICS
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2016-01-01
Address:
Basel, Basel-Stadt, Switzerland
Country:
Switzerland
Website Url:
http://www.targimmune.com
Total Employee:
1+
Status:
Active
Contact:
+41 61 225 1926
Email Addresses:
[email protected]
Total Funding:
19.35 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Nginx Euro Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS
Similar Organizations
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
NMD Pharma
NMD Pharma is a small molecule drug discovery company that develops novel treatments of neuromuscular disorders.
PIQUR Therapeutics
PIQUR Therapeutics is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs.
Pliant Therapeutics
Pliant Therapeutics focuses on discovering, developing, and commercializing breakthrough treatments for fibrotic diseases.
Sepsia Therapeutics
Sepsia Therapeutics is developing new broad-spectrum drug and cellular therapies against sepsis.
STipe Therapeutics
STipe Therapeutics focuses on harnessing the innate immune system to battle cancer.
Versameb
Versameb is focusing on the discovery and development of innovative, next-generation RNA-based drugs.
Current Advisors List
Current Employees Featured
Founder
Investors List
EASME - EU Executive Agency for SMEs
EASME - EU Executive Agency for SMEs investment in Grant - TargImmune Therapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2022-02-07 | TargImmune Announces Another Senior Hire as Veronica Hersberger Revealed As New Chief Medical Officer |
| 2021-07-18 | TargImmune raises CHF17.7 million and appoints new CEO |
Official Site Inspections
http://www.targimmune.com Semrush global rank: 4.82 M Semrush visits lastest month: 1.88 K
- Host name: 104.248.175.226
- IP address: 104.248.175.226
- Location: London United Kingdom
- Latitude: 51.5353
- Longitude: -0.6658
- Timezone: Europe/London
- Postal: SL1
